COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people

(University of Alabama at Birmingham) A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama at Birmingham this spring and summer is poised for clinical testing to begin in December. Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news